Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrea

Showing results (61-70 of 385) with videos related to

Pageof 39
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 14, 2024
MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndromeCassandra N Dennys, Sheryl Anne D Vermudez, Robert J M Deacon, et al.
Molecular Therapy Oncolytics|December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodiesLaura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2014
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activityHerbert J Zeh, Stephanie Downs-Canner, J Andrea McCart, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
Cancer Cell|July 28, 2015
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, Cory Batenchuk, Fernando A Angarita, et al.
Physical Review Letters|September 28, 2010
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHCV Khachatryan, A M Sirunyan, A Tumasyan, et al.
Physical Review Letters|September 28, 2010
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeVV Khachatryan, A M Sirunyan, A Tumasyan, et al.
Physical Review Letters|January 15, 2011
Search for dijet resonances in 7 TeV pp collisions at CMSV Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|June 1, 2019
Measurement of the <math></math> production cross section, the top quark mass, and the strong coupling constant using dilepton events in pp collisions at <math> </math>A M Sirunyan, A Tumasyan, W Adam, et al.
Pageof 39

Showing results (61-70 of 385) with videos related to

Sort By:
Pageof 39
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 14, 2024
MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndromeCassandra N Dennys, Sheryl Anne D Vermudez, Robert J M Deacon, et al.
Molecular Therapy Oncolytics|December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodiesLaura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2014
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activityHerbert J Zeh, Stephanie Downs-Canner, J Andrea McCart, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
Cancer Cell|July 28, 2015
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, Cory Batenchuk, Fernando A Angarita, et al.
Physical Review Letters|September 28, 2010
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHCV Khachatryan, A M Sirunyan, A Tumasyan, et al.
Physical Review Letters|September 28, 2010
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeVV Khachatryan, A M Sirunyan, A Tumasyan, et al.
Physical Review Letters|January 15, 2011
Search for dijet resonances in 7 TeV pp collisions at CMSV Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|June 1, 2019
Measurement of the <math></math> production cross section, the top quark mass, and the strong coupling constant using dilepton events in pp collisions at <math> </math>A M Sirunyan, A Tumasyan, W Adam, et al.
Pageof 39